Literature DB >> 21181433

Association of metabolic syndrome with reduced central serotonergic activity.

Rocio Herrera-Marquez1, Jorge Hernandez-Rodriguez, Julio Medina-Serrano, Alfonso Boyzo-Montes de Oca, Gabriel Manjarrez-Gutierrez.   

Abstract

The aim of this study was to determine the differences between two groups of adolescents with metabolic syndrome (MetS) and normal controls in relation to brain serotonergic activity through intensity-dependent auditory-evoked potentials (IDAEPs) and plasma free fraction of L-tryptophan. Eighteen adolescents with MetS and thirteen controls were studied. Free fraction, bound and total plasma L-tryptophan, glucose, cholesterol, triglycerides, HDL-cholesterol, albumin and IDAEPs were determined. Glycemia, triglycerides were significantly elevated, and HDL-cholesterol in plasma was significantly reduced. Free fraction and free fraction/total L-tryptophan ratio were decreased. The slope of the amplitude/stimulus intensity function of the N1/P2 component significantly increased in adolescents with MetS. Decrease of free fraction of L-tryptophan in plasma and increase of the slope of the N1/P2 component suggest a low brain serotonin tone. Cortex responses are regulated by serotonergic innervations and may show a different behavior in young patients with MetS. Therefore, the slope of the N1/P2 component along with the free fraction of L-tryptophan in plasma, indicate that in adolescents with MetS the state of serotonergic brain activity is depressed and possibly related to psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181433     DOI: 10.1007/s11011-010-9229-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  49 in total

Review 1.  Central nervous determination of food storage--a daily switch from conservation to expenditure: implications for the metabolic syndrome.

Authors:  Felix Kreier; Andries Kalsbeek; Marieke Ruiter; Ajda Yilmaz; Johannes A Romijn; Hans P Sauerwein; Eric Fliers; Ruud M Buijs
Journal:  Eur J Pharmacol       Date:  2003-11-07       Impact factor: 4.432

2.  Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Julia Steinberger; Stephen R Daniels; Robert H Eckel; Laura Hayman; Robert H Lustig; Brian McCrindle; Michele L Mietus-Snyder
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

3.  Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats.

Authors:  G Juckel; M Molnár; U Hegerl; V Csépe; G Karmos
Journal:  Biol Psychiatry       Date:  1997-06-15       Impact factor: 13.382

Review 4.  Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis.

Authors:  U Hegerl; G Juckel
Journal:  Biol Psychiatry       Date:  1993-02-01       Impact factor: 13.382

Review 5.  Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

6.  Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study.

Authors:  J H Morrison; S L Foote; M E Molliver; F E Bloom; H G Lidov
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

Review 7.  The spectrum of behaviors influenced by serotonin.

Authors:  I Lucki
Journal:  Biol Psychiatry       Date:  1998-08-01       Impact factor: 13.382

8.  Effect of streptozotocin-induced diabetes on tryptophan oxygenase activity and brain tryptophan levels in rats.

Authors:  E Sadler; M Weiner; G G Buterbaugh
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-10

9.  Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.

Authors:  Alexander Wutzler; Christine Winter; Werner Kitzrow; Idun Uhl; Rainer J Wolf; Andreas Heinz; Georg Juckel
Journal:  Neuropsychopharmacology       Date:  2008-05-07       Impact factor: 7.853

Review 10.  Hypertension, insulin resistance, and the metabolic syndrome.

Authors:  Andrea Natali; Ele Ferrannini
Journal:  Endocrinol Metab Clin North Am       Date:  2004-06       Impact factor: 4.741

View more
  11 in total

Review 1.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Authors:  Linda Vignozzi; Mauro Gacci; Mario Maggi
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

3.  High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice.

Authors:  Juliane Zemdegs; Gaël Quesseveur; David Jarriault; Luc Pénicaud; Xavier Fioramonti; Bruno P Guiard
Journal:  Br J Pharmacol       Date:  2015-12-09       Impact factor: 8.739

4.  Metformin Promotes Anxiolytic and Antidepressant-Like Responses in Insulin-Resistant Mice by Decreasing Circulating Branched-Chain Amino Acids.

Authors:  Juliane Zemdegs; Hugo Martin; Hiranya Pintana; Sebastien Bullich; Stella Manta; Marie A Marqués; Cédric Moro; Sophie Layé; Fabien Ducrocq; Nipon Chattipakorn; Siriporn C Chattipakorn; Claire Rampon; Luc Pénicaud; Xavier Fioramonti; Bruno P Guiard
Journal:  J Neurosci       Date:  2019-06-03       Impact factor: 6.167

5.  Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Maria Sounidaki; Georgia Antoniadi; Christos Rountas; Vassilios Liakopoulos; Loannis Stefanidis
Journal:  Mol Cell Biochem       Date:  2017-02-04       Impact factor: 3.396

6.  Non-alcoholic Fatty Liver Disease and Depression: Evidence for Genotype × Environment Interaction in Mexican Americans.

Authors:  Eron Grant Manusov; Vincent P Diego; Khalid Sheikh; Sandra Laston; John Blangero; Sarah Williams-Blangero
Journal:  Front Psychiatry       Date:  2022-07-01       Impact factor: 5.435

7.  The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes.

Authors:  Kira V Derkach; Vera M Bondareva; Oxana V Chistyakova; Lev M Berstein; Alexander O Shpakov
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

Review 8.  Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.

Authors:  Alexander O Shpakov; Kira V Derkach; Lev M Berstein
Journal:  Future Sci OA       Date:  2015-11-01

9.  How Metabolic State May Regulate Fear: Presence of Metabolic Receptors in the Fear Circuitry.

Authors:  Lisa L Koorneef; Marit Bogaards; Marcel J T Reinders; Onno C Meijer; Ahmed Mahfouz
Journal:  Front Neurosci       Date:  2018-08-27       Impact factor: 4.677

10.  Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression.

Authors:  Christian Labenz; Yvonne Huber; Maurice Michel; Michael Nagel; Peter R Galle; Karel Kostev; Jörn M Schattenberg
Journal:  Hepatol Commun       Date:  2020-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.